Mesa Laboratories [MLAB] vs Keysight [KEYS] Detailed Stock Comparison
Mesa Laboratories
NASDAQ
Loading...
Keysight
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Mesa Laboratories wins in 7 metrics, Keysight wins in 12 metrics, with 0 ties. Keysight appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Mesa Laboratories | Keysight | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 546.59 | 53.13 | Keysight |
| Price-to-Book Ratio | 2.07 | 5.09 | Mesa Laboratories |
| Debt-to-Equity Ratio | 107.21 | 48.75 | Keysight |
| PEG Ratio | 14.35 | -1.06 | Keysight |
| EV/EBITDA | 13.19 | 24.29 | Mesa Laboratories |
| Profit Margin (TTM) | -0.26% | 10.38% | Keysight |
| Operating Margin (TTM) | 5.15% | 18.12% | Keysight |
| EBITDA Margin (TTM) | 5.15% | 18.12% | Keysight |
| Return on Equity | -0.38% | 9.98% | Keysight |
| Return on Assets (TTM) | 2.04% | 5.78% | Keysight |
| Free Cash Flow (TTM) | $42.31M | $898.00M | Keysight |
| Dividend Yield | 0.88% | N/A | N/A |
| 1-Year Return | -49.28% | 12.83% | Keysight |
| Price-to-Sales Ratio (TTM) | 1.47 | 5.50 | Mesa Laboratories |
| Enterprise Value | $518.14M | $28.98B | Keysight |
| EV/Revenue Ratio | 2.14 | 5.53 | Mesa Laboratories |
| Gross Profit Margin (TTM) | 62.04% | 61.69% | Mesa Laboratories |
| Revenue per Share (TTM) | $45 | $30 | Mesa Laboratories |
| Earnings per Share (Diluted) | $-0.13 | $3.16 | Keysight |
| Beta (Stock Volatility) | 0.82 | 1.16 | Mesa Laboratories |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Mesa Laboratories vs Keysight Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mesa Laboratories | -1.53% | -0.70% | -0.82% | -38.01% | -49.26% | -51.69% |
| Keysight | 0.83% | 3.36% | 2.62% | 4.14% | 10.73% | 5.25% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mesa Laboratories | -49.28% | -58.49% | -74.04% | -42.90% | 185.28% | 391.22% |
| Keysight | 12.83% | 2.33% | 74.35% | 415.66% | 469.04% | 469.04% |
News Based Sentiment: Mesa Laboratories vs Keysight
Mesa Laboratories
News based Sentiment: NEGATIVE
The month of September brought a series of negative developments for Mesa Laboratories, including a concerning dividend payout ratio, removal from the S&P SmallCap 600, and continued bearish technical signals. These factors collectively paint a challenging picture for the company's near-term prospects, making it a high-risk investment.
Keysight
News based Sentiment: POSITIVE
Keysight delivered a strong Q3 with earnings and revenue beats, leading to increased guidance for the full year. The anticipated acquisition of Spirent Communications is progressing, and the company is actively engaging with key industry trends like AI, all contributing to a positive investment narrative.
Performance & Financial Health Analysis: Mesa Laboratories vs Keysight
| Metric | MLAB | KEYS |
|---|---|---|
| Market Information | ||
| Market Cap | $356.22M | $28.85B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 104,259 | 961,139 |
| 90 Day Avg. Volume | 112,470 | 993,250 |
| Last Close | $63.76 | $169.29 |
| 52 Week Range | $55.45 - $155.12 | $121.43 - $186.20 |
| % from 52W High | -58.90% | -9.08% |
| All-Time High | $333.42 (Dec 27, 2021) | $209.08 (Dec 27, 2021) |
| % from All-Time High | -80.88% | -19.03% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.11% |
| Quarterly Earnings Growth | 0.40% | -0.51% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.10% |
| Operating Margin (TTM) | 0.05% | 0.18% |
| Return on Equity (TTM) | 0.00% | 0.10% |
| Debt to Equity (MRQ) | 107.21 | 48.75 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $31.36 | $32.99 |
| Cash per Share (MRQ) | $4.18 | $15.34 |
| Operating Cash Flow (TTM) | $37.96M | $1.54B |
| Levered Free Cash Flow (TTM) | $33.78M | $421.62M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.88% | N/A |
| Last 12-Month Dividend | $0.80 | N/A |
Valuation & Enterprise Metrics Analysis: Mesa Laboratories vs Keysight
| Metric | MLAB | KEYS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 546.59 | 53.13 |
| Forward P/E | 8.81 | 24.09 |
| PEG Ratio | 14.35 | -1.06 |
| Price to Sales (TTM) | 1.47 | 5.50 |
| Price to Book (MRQ) | 2.07 | 5.09 |
| Market Capitalization | ||
| Market Capitalization | $356.22M | $28.85B |
| Enterprise Value | $518.14M | $28.98B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.14 | 5.53 |
| Enterprise to EBITDA | 13.19 | 24.29 |
| Risk & Other Metrics | ||
| Beta | 0.82 | 1.16 |
| Book Value per Share (MRQ) | $31.36 | $32.99 |
Financial Statements Comparison: Mesa Laboratories vs Keysight
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MLAB | KEYS |
|---|---|---|
| Revenue/Sales | $59.54M | $1.31B |
| Cost of Goods Sold | $22.60M | $492.00M |
| Gross Profit | $36.94M | $814.00M |
| Research & Development | $4.98M | $250.00M |
| Operating Income (EBIT) | $3.06M | $207.00M |
| EBITDA | $15.17M | $408.00M |
| Pre-Tax Income | $7.01M | $320.00M |
| Income Tax | $2.27M | $63.00M |
| Net Income (Profit) | $4.74M | $257.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MLAB | KEYS |
|---|---|---|
| Cash & Equivalents | $27.32M | $3.12B |
| Total Current Assets | $102.69M | $5.47B |
| Total Current Liabilities | $163.96M | $1.61B |
| Long-Term Debt | $76.90M | $2.72B |
| Total Shareholders Equity | $159.83M | $5.48B |
| Retained Earnings | $-188.94M | $6.65B |
| Property, Plant & Equipment | $29.88M | $995.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MLAB | KEYS |
|---|---|---|
| Operating Cash Flow | $5.66M | $448.00M |
| Capital Expenditures | $-757,000 | $-27.00M |
| Free Cash Flow | $11.66M | $457.00M |
| Debt Repayment | $-17.94M | N/A |
| Common Stock Repurchase | N/A | $-153.00M |
Short Interest & Institutional Ownership Analysis
| Metric | MLAB | KEYS |
|---|---|---|
| Shares Short | 398,709 | 2.63M |
| Short Ratio | 2.90 | 3.23 |
| Short % of Float | 0.11% | 0.02% |
| Average Daily Volume (10 Day) | 104,259 | 961,139 |
| Average Daily Volume (90 Day) | 112,470 | 993,250 |
| Shares Outstanding | 5.46M | 172.58M |
| Float Shares | 5.34M | 170.72M |
| % Held by Insiders | 0.05% | 0.01% |
| % Held by Institutions | 0.96% | 0.92% |
Dividend Analysis & Yield Comparison: Mesa Laboratories vs Keysight
| Metric | MLAB | KEYS |
|---|---|---|
| Last 12-Month Dividend | $0.80 | N/A |
| Last 12-Month Dividend Yield | 0.88% | N/A |
| 3-Year Avg Annual Dividend | $0.69 | N/A |
| 3-Year Avg Dividend Yield | 0.13% | N/A |
| 3-Year Total Dividends | $2.08 | N/A |
| Ex-Dividend Date | Aug 29, 2025 | N/A |